... Estimating the world cancer
burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. Non -small CellLungCancer Collaborative Group: Chemotherapy
in non smallcelllung cancer: a meta-analysis ... docetaxel as first-line chemotherapy in
patients with advanced non -small celllung cancer: a lung
cancer Galician group phase II study. Cancer Chemother Pharma-
col 2007, 60:725-732.
20. Binder D, ... cisplatin-teniposide in patients with
advanced non -small- celllung cancer. The European Organi-
zation for Research and Treatment of CancerLung Cancer
Cooperative Group. J Clin Oncol 1998, 16:2133-2141.
7....
... Non -small- celllungcancer harbouring mutations in the EGFR
kinase domain. Clin Transl Oncol 2010, 12:75-80.
9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell
lung cancer: ... of
detecting EGFR mutations in lungcancer patients.
Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell
lungcancer (NSCLC) cell lines and tumor ... of
EGFR mutations in non -small- celllung cancer. Clin Cancer Res 2009,
15:3023-3028.
13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,
Travis WD: Lung adenocarcinoma: modification...
... are often divided
into two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All major
histological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,
97:1558-1563.
11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in
lung cancer. LungCancer 2009, 65:13-18.
12. ... oesophagus, head and
neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate the
hypothesis of HPV involvement in smallcelllungcancer pathogenesis...
... marker expression in tumor cells versus stromal cells in non
small celllung cancer. Clin Cancer Res 2007, 13:6649-57.
24. World Health Organization: Histological Typing of Lung and Pleural
Tumours. ... in
non -small celllung cancer. Clin Cancer Res 2008, 14:5220-7.
30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts of
hypoxic markers according to NSCLC histology. LungCancer ... Paclitaxel-carboplatin alone or with
bevacizumab for non -small- celllung cancer. N Engl J Med 2006,
355:2542-50.
21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol
2007, 18(Suppl 9):ix135-ix142.
22....
... Staging of small cell
and non -small celllung cancer. University of Iowa Virtual Hos-
pital; 1999.
6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-
ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,
95(6):683-90.
17. Cancer Research UK [http://www.cancerresearchuk.org
]
18. Cancer Help [http://www.cancerhelp.org.uk
]
19. Association for International Cancer ... Research and Treatment of
Cancer Quality-of-Life Questionnaire -Lung Cancer- 17
items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-
related Quality of Life; NSCLC: Non -Small CellLung Can-
cer; SF-36:...
... gefitinib in non -small celllungcancer
cell lines. Mol Cancer Res. 2006; 4(8): 521-8.
102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non -small- celllungcancer patients ... cause of cancer death world-
wide (1). Lungcancer is generally classified into two
histological types, smallcelllungcancer (SCLC) and
non smallcelllungcancer (NSCLC).
NSCLC accounts
for ... in non -small
cell lungcancer Is correlated with survival. Clin Cancer Res.
2001; 7(7): 1850-5.
93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated
non -small- celllung cancer...
... induced by
first-line chemotherapy with single agent
docetaxel in a patient with advanced non small
celllung cancer
Ferdinando Riccardi
1*
, Giuseppe Di Lorenzo
1
, Carlo Buonerba
1
, Guglielmo Monaco
2
, ... Carteni’
1
Abstract
Background: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... few cycles should not
automatically discourage to continue treatment.
Introduction
In non -small celllungcancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum of
severity....
...
stage smallcelllung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.
31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors
predicting radiation pneumonitis in lungcancer ... of unresectable locally advanced non-
small celllungcancer (NSCLC). Unfortunately, the longer
survival is achieved at the price of greater toxicity of the
lung and the esophageal mucosa [3-5].
* ... Komaki R, Mohan R:
Dose and volume reduction for normal lung using intensity-
modulated radiotherapy for advanced-stage non -small- celllung
cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267.
21....
... non -small- cell lung
cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.
16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy
in treatment of stage I non -small celllung ... non -small- celllung cancer: clinical implications. Radiother Oncol
2010, 94:1-11.
27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic body
radiotherapy for T1-3N0 non -small celllung ... for lungcancer varied greatly from
institution to institution [10]. The most frequently used
schedule was 48 Gy in 4 fractions for both stage IA and
IB primary lungcancer and metastatic lung cancer.
As...
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer
Background
Non -small celllungcancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients ... Okunieff
2
and Michael T Milano
1*
Abstract
Background: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemic
chemotherapy and/or radiotherapy. Recent studies ... Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non -small celllung cancer
Praveena Cheruvu
1
, Su K Metcalfe
1
, Justin Metcalfe
1
, Yuhchyau Chen
1
, Paul...
... surgery in patients with
operable lung cancer.
A randomized phase III trial of Radiosurgery Or Surgery
for operable Early stage (stage 1A) non -small cell Lung
cancer (ROSEL, ClinicalTrials.gov ... radiotherapy for stage I
non -small celllung cancer. Radiother Oncol 2007, 85:429-434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana university ... options for stage I
non -small celllung cancer. Oncologist 2008, 13:309-319.
41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:
Review of Hypofractionated Small Volume Radiotherapy...
... energy agency (IAEA)
consultants' meeting on elective nodal irradiation in lung
cancer: non -small celllungcancer (NSCLC). Int J Radiat Oncol
Biol Phys 2008, 72(2):335-342.
6. Therasse P, ... in non -small celllung cancer
Erik P Sulman, Ritsuko Komaki, Ann H Klopp, James D Cox and
Joe Y Chang*
Address: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer ... node stations.
Methods: We retrospectively reviewed the records of 115 patients with non -small cell lung
cancer treated at our institution with definitive radiation therapy with or without concurrent
chemotherapy...
... for Cancer Control and
Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and
3
JCOG lungcancer study group, Thoracic
Oncology Division, National Cancer ... Access
Research
Radiotherapy quality assurance review in a multi-center
randomized trial of limited-disease smallcelllung cancer: the Japan
Clinical Oncology Group (JCOG) trial 0202
Naoko Sanuki-Fujimoto
†1
, ... types of consolidation
chemotherapy after concurrent chemoradiotherapy for limited-disease smallcelllung cancer. RT
requirements included a total dose of 45 Gy/30 fx (bis in die, BID/twice a day)...
... relationship
between the target and the parotid glands [8]. Similar
findings were made for non -small- celllung cancer
(NSCLC), where a continuous tumor regression during
radiotherapy was observed [9].
This ... Wagner
TH, Langen KM: Serial megavoltage CT imaging during exter-
nal beam radiotherapy for non -small- celllung cancer: obser-
vations on tumor regression during treatment. Int J Radiat
Oncol Biol Phys ... Access
Research
Evalution of surface-based deformable image registration for
adaptive radiotherapy of non -small celllungcancer (NSCLC)
Matthias Guckenberger*, Kurt Baier, Anne Richter, Juergen Wilbert and
Michael...